Investment Strategy Partners

ISP acted as sole commercial advisor for an investment in VALEARA - a leading provider of ambulatory mental healthcare services in Germany

ISP acted as sole commercial advisor for an investment in AAC Praxisberatung - the leading software-based service provider for controlling and auditing of billing for physicians in Germany's statutory health insurance (GKV) system

ISP acted as the exclusive buy-side M&A advisor for the acquisition of DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen – a well-established German Regulatory Affairs and Pharmacovigilance consultancy

ISP performed the Commercial VDD for the seller of Pentapharm AG – a leading supplier of biological agents for pharmaceutical and diagnostic applications with unique expertise in the field of haemostasis

ISP acted as sole commercial advisor for an investment in KLmed – a leading personnel service provider for medical healthcare facilities

ISP acted as sole commercial advisor for an investment in Bioarray – a leading Spanish diagnostic and research laboratory specializing in advanced genetic testing

ISP acted as sole commercial advisor for an investment in Paracelsus' rehab division – a leading German rehabilitation provider

ISP acted as the exclusive buy-side M&A advisor for the acquisition of S-cubed – a well-established UK-based Regulatory Affairs and Quality Assurance consultancy

ISP acted as exclusive buy-side M&A advisor for the acquisition of Quantify – a leading player in real-world evidence generation, health economics & outcomes research

ISP acted as exclusive buy-side M&A advisor for the acquisition of Biomapas – a leading player in pharmaceutical clinical research

ISP acted as sole commercial advisor for an investment in DMRZ – a leading cloud-based billing software for other healthcare providers

ISP acted as sole commercial advisor for the Vendor CDD Otto LSE – the leading EPC provider for GMP pharma production facilities in Central Europe

ISP acted as sole commercial advisor for an investment in A.R.C. Laser and Neolaser – two leading medical laser manufacturers

ISP acted as sole commercial advisor for an investment in VAMED – a major European stationary rehab provider

ISP acted as sole commercial advisor for an investment in Dermlite – the leading US Dermatoscope device manufacturer

ISP acted as sole commercial advisor for an investment in SDS – leading ceramic dental implant manufacturer

ISP acted as sole commercial advisor for an investment in Imes-icore – leading dental milling machine manufacturer

ISP acted as sole commercial advisor for the Vendor CDD Academia – leading DACH genetics/pathology laboratory platform

ISP acted as sole commercial advisor for an investment in CRS medical GmbH – a leading supplier of non-point-of care defibrillators

ISP acted as sole commercial advisor for an investment in MLase – the leading CDMO for medical excimer lasers

ISP acted as exclusive buy-side strategic transaction advisor for the Series B investment into Geneplanet – a preventive genetic testing player

ISP acted as sole commercial advisor for an investment in Sonnen Gesundheitszentrum – a leading laboratory for hemostaseology in Germany

ISP acted as sole commercial advisor for an investment in Genetikum – the leading laboratory for human genetics in Germany

ISP acted as strategic advisor to Laboratoire XO – a pharma co. focused on mature market authorizations, in their majority acquisition by Stanley Capital

ISP acted as sole commercial advisor for an investment in Heintel Medizintechnik – Austrians leading hospital focused MedTech distributor

ISP acted as sole commercial advisor for an anchor investment in Nexus – a leading hospital information system provider